MBIO News and Press, Mustang Bio Inc. From 09/22/20

WORCESTER, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

Were These Penny Stocks On Your List Today? The market’s closed but that doesn’t mean you should stop looking for the best penny stocks today . The reason being is that sometimes late afternoon momentum can dictate the pace of the upcoming Monday session. Do all penny stocks w...

Penny Stocks To Watch This Month Trading penny stocks is easy. You just find some letters, pull up the order-entry ticket, buy, sell, and profit, right? While the process of actually buying penny stocks is simple, the strategy isn’t quite as easy. Anyone can get lucky trading penny ...

WORCESTER, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

The FDA has granted Orphan Drug Designation to Mustang Bio's (NASDAQ: MBIO ) MB-107, a lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency (“XSCID”), a rare genetic disorder in newly diagnosed infants under the age of two. More news on: ...

WORCESTER, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

WORCESTER, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...

Investment Thesis Mustang Bio share price performance since joining Nasdaq. Source: TradingView Mustang Bio ( MBIO ) is looking like an increasingly attractive investment opportunity within the gene and CAR-T therapy space. Mustang is a wholly owned subsidiary of Fortress Bio , and op...

The FDA grants Rare Pediatric Disease Designation to Mustang Bio's (NASDAQ: MBIO ) lead gene therapy candidate MB-107 for the treatment of X-linked severe combined immunodeficiency (XSCID), also known as bubble boy disease, in newly diagnosed infants. More news on: Mustang Bio, Inc., H...

CureVac (NASDAQ: CVAC ) +47%  on making reasonable profit on COVID-19 vaccine. More news on: CureVac N.V., LMP Automotive Holdings, Inc., Microbot Medical Inc., Stocks on the move, , Read more ...